PROPEL

New PROPEL Survey Feature

August 11, 2023 by

In the fast-paced world of clinical trials, feasibility surveys have become a crucial step in the process. These surveys help researchers determine the viability of their trials and ensure that all the necessary resources and capabilities are in place. However, it is important to recognize that surveys have the potential to be powerful tools in various other aspects of clinical research. Building relationships, understanding site capabilities, and gathering feedback are just a few of the areas where surveys can prove to be invaluable. 

Surveys are an incredibly powerful tool, allowing researchers to collect feedback and insights from a wide range of recipients. Whether it’s gathering information from sites within your network, potential vendors, patients, or investigators, surveys can provide valuable data that can inform important decisions. 

PROPEL Enterprise’s new Survey Feature is an exciting development for the clinical trial industry. With this innovative tool, researchers can create and distribute surveys directly within the platform, reaching a large audience and gaining valuable data in a streamlined and efficient manner. 

How It Works 

PROPEL Enterprise‘s new Survey Feature functionality (GIF). 

Quickly create and send surveys directly within PROPEL to LYNK users or external email lists. Use pre-built templates, import existing questions, or create a survey from scratch with PROPEL’s easy-to-use interface. For ease of tracking, you can also associate your survey with a specific trial, contact, or account. 

Once a survey is sent, PROPEL will automatically collect all timing and response data in one place for easy monitoring and reporting – giving you real-time visibility into who has completed a survey, who hasn’t, and who stopped part-way through. But the feature doesn’t stop there – eliminate endless follow-up emails with automated alerts and reminders. 

Instead of relying on multiple programs and websites to send and track surveys, PROPEL provides a closed-loop system allowing you to make surveys, send them out, and to get in-depth analytics on responses and timing.  

For Any Kind of Survey 

Survey Feature interface. 

PROPEL’s new feature aims to transform and streamline the survey process – from feasibility and CSAT to PI onboarding, equipment management, and beyond! Surveys can be as general or specific as you want and for any use case under the sun. Want to know what kind of studies sites are looking for? Need to follow-up with a site or PI about a recent onboarding? PROPEL’s new Survey Feature is here to help! 

Ready to see how Devana Solutions continues to revolutionize how clinical research professionals gather and analyze feedback? Schedule a demo today! 

Devana Solutions  

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.  

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.  

PROPEL

PROPEL Spring ’23 Update

May 26, 2023 by

Get ready for an exhilarating update to PROPEL! The Spring ’23 Update brings a plethora of enhancements, refinements, and additions to the platform designed to improve and streamline the user experience system wide with a heavy focus on Trials and Trial Management.  

PROPEL’s latest release is all about optimizing glanceability and improving workflows while prioritizing the information that means the most, from harmonized field names to a new glossary for credentials and the release of Trialstones. The theme underlining the entire release can be summed up as “Trials” – which have been given a complete makeover, including new Trialstones, streamlined tabs and fields, and a progress bar to keep track of trial status. 

What’s New? 

The user interface (UI) has been updated and enhanced across several areas of the platform so everything can be quickly absorbed at a glance. A key part of the updated UI is the new progress bar, which clearly shows what stage a trial is currently in. New, more visually compelling monitoring tiles have replaced checklists in various places, making content more scannable and insights digestible. See below for a look at the new real-time progress bar and pre-award Trialstones tiles.  

PROPEL Trial page with new progress bar and pre-award Trialstones.

What’s a Trialstone, you ask? Pre- and post-award trial milestones are now known as Trialstones throughout the platform. When sites complete Trialstones such as CDA Executed or PSV Complete, this information will be updated across the system – including advancing the trial stage in the new progress bar. Users can track and manage Trialstones directly from any trial page within PROPEL for improved workflows. With the new update, Trialstones can also be updated for multiple sites at once to save time.  

Another great new feature coming in this update is that trials can now be marked as high priority. Making a trial high priority adds a red star to the list view, clearly calling out trials which have been flagged. This new feature allows central team users to delineate which opportunities and trials sites should focus on first. 

We’ve only covered some of the broader highlights, but the Spring 2023 Update brings a lot of exciting new quality of life changes to PROPEL and LYNK. Full release notes and training materials have already been made available to our existing partner-clients. If you’re interested in learning more, please contact us today and we’d be happy to give you a demo of our game-changing platform. 

Devana’s product development pipeline has more exciting updates and features coming soon, so stay tuned!  

Devana Solutions  

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.  

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.  

PROPEL

Accelerate Study Cycle Times with Clinical Trial Software for CROs

April 27, 2023 by

In our post-pandemic world, contract research organizations (CROs) face more challenges than ever. With greater competition, market consolidation, and a growing emphasis on site empowerment, the CRO market is in a state of flux. Only those willing to be flexible as they apply learnings from the COVID-19 pandemic and its aftermath are likely to come out ahead.   

One of the key takeaways from the COVID-19 pandemic applied throughout the clinical trial industry is to invest in mission-critical technology. Devana Solutions’ category-defining PROPEL platform offers improved site selection, real-time communication, and site collaboration. PROPEL provides process and performance transparency while automating workflows, accelerating cycle times, and reducing the overall workload for CROs and sites. 

Improved Site Selection 

PROPEL Site Query Functionality

CROs have long relied on manual, time-consuming processes to identify the most suitable sites for new clinical trials. With PROPEL, we’ve eliminated this outdated approach. 

PROPEL enables CROs to perform targeted queries to determine suitable sites for new trials. Find the most effective sites in real-time by digitally querying site capabilities based on therapeutic expertise, physical site facilities, investigator and staff certifications, and more. PROPEL automatically stores site and investigator performance and capabilities data to share with sponsors or use for future trials.  

With PROPEL, CROs can be confident in the sites they’ve selected when reporting back to sponsors with progress updates. 

Real-Time Collaboration 

When you have a clinical trial underway, it’s important to have a tool that makes it easy for you to share information with sites—and receive real-time responses. 

Forget endless follow-up emails, calls, and meetings. Instead, push out mass communications or individually tag relevant users or site teams, alerting them of new trial opportunities, updates, or queries. PROPEL’s threaded chat conversations allow CROs and sites to pose questions, share documents, and provide updates. Real-time feedback from sites, such as if there are too many inclusion/exclusion criteria or more realistic estimates for patient enrollment, can help CROs with sponsor bid defenses. Sites can also ask questions and share documents via the same channels—keeping everyone in the loop throughout the entire clinical trial process.  

With PROPEL, CROs also gain insights into other site organizations already using PROPEL, including two of the largest site networks and the largest site organization in the world. 

Performance Transparency 

 

PROPEL Site Activity Dashboard

When running clinical trials, you need to be able to track and analyze current and historical metrics. This is where PROPEL comes in. 

Tracking current and historical trial metrics with PROPEL’s dashboards and reports can help CROs win more sponsor bid defenses by quantifying past successes and showcasing real-time updates for trials currently running. Key data generated throughout the clinical trial process is automatically stored within PROPEL and can be accessed via custom reports and visualizations whenever needed. Know exactly how a trial progresses from site selection to completion with real-time data capture and analysis. Identify bottlenecks in terms of site responses, patient enrollment, and more so you can step in and provide targeted support where needed.  

Sharing the latest data anytime with stakeholders and sponsors is critical to accelerating cycle times and mitigating bottlenecks and risks.  

Want to learn more? Download the PROPEL sell sheet.  

Devana Solutions  

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.  

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.  

About Us | Analytics | Clinical Trials

Devana Solutions CEO Barry Lake on Note to File Podcast

June 1, 2022 by

Devana Solutions CEO Barry Lake recently sat down with Brad Hightower of the Note to File Podcast to discuss the current state of the industry and the importance of sites tracking their own metrics using clinical trial software like Devana Solutions.

Offering holistic trial analysis and a dynamic site and investigator database, Devana Solution’s enterprise software gives businesses the crucial support and data management they need to focus on their own business efforts and core competencies. We understand the unique challenges of the clinical trials industry and offer comprehensive solutions such as automated data evaluation and communication, freeing teams from repetitive tasks so they can focus on winning more study contracts.

For life-saving therapies and vaccines to reach patients more quickly, leading research organizations turn to Devana Solutions for cutting-edge cloud-based SaaS technology and services in the clinical trial industry.

Check out Barry’s episode of the Note to File Podcast here.

Note to File Podcast

Note to File is a podcast for clinical research sites, featuring interviews, best practices, and candid commentary from host Brad Hightower, founder of Hightower Clinical and clinical research professional. The podcast was born with the hope of providing a resource for research professionals to share their stories and serve as a source for practical advice for the clinical research community.

Devana Solutions

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.

About Us

Devana Solutions Welcomes Alex Schneider as Head of Product

May 5, 2022 by

Alex SchneiderDevana Solutions is excited to welcome Alex Schneider as Head of Product.

Alex comes to Devana Solutions with over 13 years of experience in user experience research and design, competition intelligence, and product management. Alex joins us from Westat, where he spent over five years, most recently as Head of UX.

Alex has spent his career architecting and delivering innovative, intuitive solutions to hundreds of thousands of researchers, participants, and people across the globe. A staunch advocate for users of all kinds, he works with executives and clients to understand and translate problems and needs into actionable, efficient and effective experiences.

As Head of Product, Alex is responsible for determining product strategy, development, execution, and implementation. He will help define Devana Solution’s product roadmap to deliver world-class experiences by driving innovation through data analysis and qualitative customer feedback.

“Alex epitomizes the expertise the Head of Product for a high-growth SaaS solutions provider like Devana Solutions requires going forward. As the point person from product strategy to go-to-market, there are few more qualified than Alex Schneider. He will be a great compliment to our outstanding leadership team,” says Devana Solutions CEO & Co-founder Barry Lake.

Devana Solutions is thrilled to have Alex join our team – we know he’ll help us do great things!

PROPEL

Improve Study Outcomes with Clinical Trial Software for CROs

April 28, 2022 by

The relationship between sponsors and contract research organizations (CROs) is strengthening as outsourcing becomes a clinical trial norm. It is important for the CRO to have a good working relationship with sites in order to ensure that the trial is successful, particularly in the study startup phase, as clinical trials are increasingly expensive and time-consuming endeavors.

Key factors that influence a good relationship and where clinical trial software can help are:

  • Targeted Site Selection
  • Digitized Feasibility
  • Enhanced Site Collaboration and Communication
  • Process and Performance Transparency

Targeted Site Selection

More complex protocols require more precise site selection. Devana’s PROPEL technology allows for CROs to perform automated queries during site selection to determine the right sites or investigators based on the requirements of the protocol. PROPEL allows CROs to store the site and investigator performance and capabilities data that can be managed and updated by the sites, in real-time, allowing for more accurate site selection. Sponsors can be confident that the sites selected by the CRO will be capable of meeting performance expectations, resulting in better study outcomes.

Digitized Feasibility

While feasibility questionnaires are certainly a critical piece to selecting the right sites for a trial, the entire process, as it is today, is a bit archaic. Devana is revolutionizing the feasibility process by allowing CROs to submit a digitized feasibility to the sites selected for each trial. Say goodbye to outdated PDFs and third-party websites. This digital feasibility will pre-populate information that typically remains the same, trial to trial, such as the site’s location and contact information, but allows for the CROs to receive new, trial-specific data such as subject population criteria. The sites can review their previously submitted data for accuracy and respond to any new inquiries, resulting in a speedier feasibility process and a lower cost for the Sponsor.

Enhanced Site Collaboration and Communication

In addition to improving the feasibility process, Devana took it a step further by creating a threaded communication feed between the sites and CROs within the PROPEL platform. If a Sponsor reaches out to a CRO about a trial in bid-defense, needing to quickly know the potential subject pool for a particular indication, the CRO can instantly push out a mass communication to the sites and gather their responses within the platform. No more cumbersome calls or emails to track. Just the same, if a CRO submits a site for a trial, the site can review the details and provide feedback to the CRO or ask questions related to the protocol. It’s a win-win for all involved, the site, the CRO and the Sponsor, since this connectivity allows for more efficient communication throughout the entire clinical trial process.

Process and Performance Transparency

Another important aspect of a good working relationship between Sponsors and CROs is process and performance transparency. The entire clinical trial process, from study startup through close-out, produces a lot of key data. By using PROPEL, CROs have real-time views into the trial, by site, to know exactly where the trial is at any given time. The ability to quickly obtain this data and provide to Sponsors is critical to the swift and successful execution of a trial and the ability to mitigate risk.

Devana Solutions

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.

PROPEL

Boost Study Contract Wins in the Clinical Trial Industry

April 11, 2022 by

Is your clinical trial organization looking to boost study contract wins and shorten the sales cycle? Then you need to ensure you have the right tools in your tech stack. In the age of technology, there are many options available but one you must include is a trial startup software that synchronizes your communication and data for increased efficiency.

A quality trial startup technology solutions provider, like Devana Solutions, will understand the unique challenges of the industry and offer comprehensive solutions such as automated data evaluation and communication that frees the sales team from repetitive tasks so they can focus on winning the study contract.

Devana Solutions Saves Time and Shortens Sales Cycles

By eliminating repetitive tasks, Devana Solutions’ PROPEL platform is able to shorten the overall sales cycle. Put an end to the tedious work in spreadsheets or disparate systems, as PROPEL is able to automate sales processes, capture a complex chain of emails, and account for customized variations.

In addition, PROPEL allows for each cross-functional team to seamlessly communicate with one another and understand what stage the trial is in during the startup process. The best software will be easily accessible to every decision-maker across the trial management process.

How Trial Software Software Boosts Sales in the Clinical Trial Industry

Increased data means more informed decision-making. With a vibrant and dynamic site and investigator database, as well as up to date performance metrics, the sales team is able to focus their efforts to determine the best trial opportunities for their organization. Increased data streams allow the organization to predict how their business development strategies will affect their overall operations.

Choosing the Best Trial Startup Software for Your Clinical Trial Business

The best clinical trial software will be one that is designed with the unique challenges of the clinical trials industry in mind. Offering holistic trial analysis and a dynamic site and investigator database, Devana Solutions’ PROPEL enterprise software gives businesses the crucial support they need to focus their business efforts for much success.

Sign up for a free demo and learn what makes PROPEL the best in the industry.

Devana Solutions

Devana Solutions is an innovative cloud software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.

Events

2022 World Vaccine Congress: What to Expect

March 29, 2022 by

Devana Solutions executives are attending the 2022 World Vaccine Congress in Washington D.C., on April 18-21, 2022. Here’s what leaders in the biopharma industry can expect.The World Vaccine Congress, in existence for over two decades, has grown to become the largest and most established conference dedicated to vaccines, globally. The World Vaccine Congress 2022 will bring together thousands of industry experts across the entire vaccine landscape, with key sessions dedicated to the fight against COVID-19. Taking place April 18-21 at the flagship hotel, Marriott Marquis Washington, DC, the event will be one of the first opportunities to meet in person since the pandemic began to learn, share experiences and ground-breaking knowledge, and network with others who are working against COVID-19 and on other important vaccines.

“If there is anything that the last two years have taught this industry, it’s that the pandemic has certainly put the focus on the need for cutting-edge research to produce more and better vaccines,” Devana Solutions CEO and Co-Founder Barry Lake.

Inside Peek: 2022 World Vaccine Congress Washington

An event that prides itself on covering every subject across the entire vaccine value chain, here is what to expect if you are attending:

  • Visionary Presenters
  • Engaging Agenda
  • Networking Breaks
  • Vaccine Excellence Awards

Visionary Presenters

This year’s presenters are disruptors and visionary industry leaders from the biopharma industry. They are selected for their relevance, dynamism, and insight. Just a handful of speakers at the World Vaccine Congress include:

Engaging Agenda

From basic research to commercial manufacture, World Vaccine Congress covers the whole vaccine value chain where science, government and manufacturers all come together to create ground-breaking progress. If you are involved in vaccines or new to it because of the pandemic, World Vaccine Congress is the most important meeting you will be part of in 2022.

Here are some of the topics discussed each day:

April 18

  • Biodefense and preparedness
  • Maternal immunization
  • Vaccine Technology
  • Antimicrobial resistance
  • Antibodies in treating COVID and infectious diseases
  • HIV

April 19

  • Plenary Sessions
  • Interactive roundtable discussions
  • Evening drinks & ViE Awards Dinner

April 20 & 21

  • COVID, influenza and other respiratory diseases
  • Immune profiling
  • Cancer immunotherapy
  • One health and veterinary vaccines
  • Clinical trials and development
  • Manufacture
  • Safety
  • Market access
  • Supply & logistics
  • Newly infectious and chronic diseases

Networking

Being the first in-person World Vaccine Congress since 2020, networking is an essential part of the conference experience. You can find new opportunities to collaborate or meet other people in your field. With over 30 scheduled networking events, from coffee breaks to luncheons, there is ample opportunity to learn and network with colleagues across the industry.

Vaccine Excellence Awards

On Tuesday, April 19th, the World Vaccine Congress will be hosting the 15th Annual Vaccine Industry Excellence Awards Ceremony & Dinner. The Scientific Advisory Board members will help make the final decision in each category, and the winners will be announced at the dinner.

“Devana Solutions is proud to have supported many of the leading vaccine research site organizations that stepped up in a big way during the COVID pandemic, including hyperCORE International, Benchmark Research, Centricity Research, Javara Research, Velocity Clinical Research and Accel Research Sites. We wanted to be in Washington, D.C. to support many of these clients nominated for well-deserved Vaccine Excellence Awards,” said Lake.

Are you planning on attending the 2022 World Vaccine Congress Washington? We’d love to chat. Devana Solutions’ CEO and Co-founder Barry Lake and Director, Strategic Partnerships, Emily Hardy, will be attending the show in the nation’s capital and are available to discuss how technology can improve your clinical trial management process. Connect with Barry or Emily on LinkedIn or use the contact form at the bottom of the page to set something up before the big event!

About Us

Devana Solutions Enhances Advisory Board with Addition of Velocity Clinical Research’s Craig Koch

March 17, 2022 by

[Chapel Hill, NC, March 17, 2022] Devana Solutions, the leading cloud SaaS provider to the clinical trials industry to connect centralized research professionals to staff and clinicians at decentralized site locations, announced today that industry veteran Craig Koch has joined Devana’s Advisory Board. Koch is currently Executive Vice President of Velocity Clinical Research, a leading integrated research organization in the U.S. with global expansion now underway. Koch will join current Syneos Health Senior Vice President Tom Wollman and longtime software investor and advisor Reid Conrad currently on Devana’s Advisory Board.

“I am delighted to have Craig join our Advisory Board,” stated Barry Lake, Devana Solutions’ CEO, “Velocity Clinical Research is perhaps the most optimized organization now leveraging our advanced PROPEL enterprise platform, and Craig’s analytical skills and leadership are a big reason why. I look forward to his contributions as an advisor to Devana Solutions, particularly with the transformative development initiatives Devana will be delivering to the industry in 2023.”

“Devana Solutions’ began as a tool for clinical research sites where it will remain the gold standard for research site productivity. The flexibility of the platform and the talent of the team also position Devana to be a Solution poised to unify what is a very disjointed industry.”

Founded in 2017, Velocity has grown dramatically in the last few years and now comprises 30 research sites across the United States with current global expansion underway. The Velocity model represents a new approach to site management. By owning and operating all sites directly, the organization offers a robust infrastructure that completely integrates the sites with singular systems and processes. Their model has proven to provide consistent and predictable patient recruitment and engagement. From a systems perspective, Velocity is an extremely technology-enabled organization, and under Koch’s direction, the Devana Solutions platform lies at the heart of Velocity’s business development, feasibility, and pre-award workflows, and both trial enrollment and overall business performance analytics.

According to Lake, “Craig’s expertise in leveraging our technology and industry insights will be a strong addition to Devana’s Advisory Board and our company. I look forward to his contributions.”

About Devana Solutions

Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions’ innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials. https://devanasolutions.com/

About Velocity Clinical Research

Velocity Clinical Research, headquartered in Durham, NC, is the leading integrated site organization for clinical trials, offering dedicated site capabilities to help biopharmaceutical and contract research organization customers find the right patients for their studies. Velocity supports global drug development in primarily conducting phase II and phase III clinical trials. The company has 30 U.S. locations across 14 states. Velocity places the care of the patient at the heart of everything we do. With over 35 years of experience running sites and more than 7,000 studies completed, Velocity has refined its patient recruitment strategies while maintaining a focus on delivering timely and reliable data quality. For more information. visit our website at https://velocityclinical.com.

About Us | IGNITE | Partner Spotlight | PROPEL

Devana Solutions Connects Research Operations and Business Intelligence at Scale with Clinical Conductor Integration

March 10, 2022 by

A new interface between Devana’s IGNITE and PROPEL products and Advarra’s Cloud-Based Clinical Trial Management System establishes an end-to-end solution for efficient research conduct and world-class business intelligence.

CHAPEL HILL, NC (March 10, 2022) – Devana Solutions is pleased to announce a new, at scale CTMS- integration solution for research organizations utilizing Advarra’s Clinical Conductor Clinical Trial Management System (CTMS), improving efficiency, and providing research sites with actionable insights across their entire research portfolio.

The Devana <-> Advarra integration is a dynamic, bi-directional data and process flow between Devana’s IGNITE and PROPEL products, and Advarra’s industry-leading Clinical Conductor CTMS. Following the natural progression of a trial, the trial startup begins in Devana, flows through Clinical Conductor for clinical execution and research operations management, and then back to Devana for end-to-end business intelligence. Enrollment performance metrics are derived automatically and pulled into the Devana system as research teams are interacting with Clinical Conductor, reducing duplicative workflows within the systems.

The robust and sought-after analytics, available within the Devana systems, offer configurable views to analyze performance data, by trial or indication, by site, or organization-wide. Combined with Clinical Conductor’s ability to optimize operational finances, regulatory compliance, and overall operational workflows, these integrated products provide a seamless, comprehensive, clinical research solution. After a very thorough and thoughtful technical approach, the Devana <-> Advarra CTMS integration is now live for all Clinical Conductor customers.

“At Devana Solutions, we have always prided ourselves in listening to our clients and being attentive to their needs,” explained Barry Lake, Devana Solutions’ CEO. “So, when the leadership at highly-valued client-partners, Javara Research and Velocity Clinical Research, encouraged an API-integration with Advarra’s Clinical Conductor CTMS to better support their study teams, we were eager to explore it.”

“We were pleased to work closely with the team at Advarra and the integration of both systems has increased our clients’ operational efficiency. We look forward to deploying the connection for the benefit of additional mutual clients. Working together, as an industry, we can and will move mountains!” added Lake.

“We are thrilled to collaborate with Devana and our customers on this innovative interface,” said James Wurdeman, Chief Product Officer at Advarra. “Devana’s approach to developing this integration aligns with our philosophy of creating site-centric, open, customer-focused technology solutions that can be integrated with enterprise systems across a research site or site network.”

Devana Solutions now boasts integrations with several leading CTMS technologies on the market. These integrations speak to more than just added convenience and increased efficiencies; they’re speeding up the clinical trial process resulting in improved clinical outcomes and therapies to patients.

About Devana Solutions

Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials. https://devanasolutions.com/

About Advarra

Advarra makes clinical research safer, smarter, and faster. Our integrated solutions help safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance for over 3,500 sponsors, CROs, institutions, academic medical centers, and research consortia.

With trusted and unequaled independent oversight committee services, innovative software solutions for sites, sponsors, and CROs, and experienced consultants with deep-seated connections across the industry, Advarra has the expertise and technology needed to advance clinical research and help our clients make the world a healthier place.

Headquartered in Columbia, Maryland, Advarra’s extensive geographic reach helps clients navigate the evolving research and regulatory environment. https://www.advarra.com/

1 2 3 4